CompletedPHASE1, PHASE2NCT06449040

Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospital Universitário Professor Edgard Santos
Principal Investigator
PAULO MACHADO, MD, PhD
Federal University of Bahia
Intervention
Liposomal amphotericin B (AmBisome®)(drug)
Enrollment
28 target
Eligibility
60 years · All sexes
Timeline
2019 – 2023

Study locations (1)

Collaborators

Instituto Gonçalo Muniz FIOCRUZ BA

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06449040 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials